✦ LIBER ✦

Evaluation of safety and efficacy of a herbal extract HD03-ES in HBeAg negative chronic hepatitis B: An open clinical study

✍ Scribed by P. Patki; M. Tandon

Book ID: 119238967
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 60 KB
Volume: 2
Category: Article
ISSN: 1876-3820
DOI: 10.1016/j.eujim.2010.09.082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of entecavir versus

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

✍ Yun-Fan Liaw; Maria Raptopoulou-Gigi; Hugo Cheinquer; Shiv Kumar Sarin; Tawesak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

A randomized, open-label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic decompensation (Child-Turcotte-Pugh score ≥7). Adult subjects were randomized and treated (n = 191) with entecavir 1.0 mg or adefovir 10 mg daily for up

749 EFFICACY AND SAFETY OF PEGINTERFERON

749 EFFICACY AND SAFETY OF PEGINTERFERON alfa-2a (40KD) IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS PARTICIPATING IN A RESPONSE-GUIDED THERAPY STUDY: AN INTERIM ANALYSIS AT WEEK 72

✍ Hou, J.; Ma, H.; Sun, J.; Xie, Q.; Xie, Y.; Sun, Y.; Wang, H.; Shi, G.; Wan, M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 219 KB

539 2-YEAR RESULTS OF TELBIVUDINE (LDT)

539 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS

✍ T. Piratvisuth; P. Komolmit; T. Tanwandee; W. Sukeepaisarnjaroen; H.L. Chan; M.G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

1181 A phase III, partially double-blind

1181 A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2A (40KD) (PEGSYS®) alone or in combination with lamivudine vs lamivudine in 546 patients with HBEAG-negative/anti-HBE-positive chronic hepatitis B

✍ MARCELLIN, P; LAU, G; BONINO, F; FARCI, P; HADZIYANNIS, S; JIN, R; LU, Z; PIRATV 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

1036 A 24-WEEK, PARALLEL-GROUP, OPEN-LAB

1036 A 24-WEEK, PARALLEL-GROUP, OPEN-LABEL, RANDOMIZED CLINICAL TRIAL COMPARING THE EARLY ANTIVIRAL EFFICACY OF TELBIVUDINE AND ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B

✍ Zheng, M.-H.; Shi, K.-Q.; Dai, Z.-J.; Ye, C.; Chen, Y.-P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

An open clinical study assessing the eff

An open clinical study assessing the efficacy and safety of Factor IX Grifols®, a high-purity Factor IX concentrate, in patients with severe haemophilia B

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAWILSKA; L. GERCHEVA; A. ANTONOV; M. MONTAÑES; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB